Last reviewed · How we verify

NCT04652934

Effectiveness of the Neural Mobilization on Upper Limb Functionality in Patients With Acquired Brain Injury

Completed NA Last updated 1 August 2023
What this trial tests

NA trial testing Neurodynamic in Hemiplegia and Hemiparesis in 24 participants. Completed in 28 July 2023.

Timeline
26 January 2022
Primary endpoint
28 July 2023
28 July 2023

Quick facts

Lead sponsorVanesa Abuín
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment24
Start date26 January 2022
Primary completion28 July 2023
Estimated completion28 July 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Vanesa Abuín

Who can join

Adults 25 to 50, any sex, with Hemiplegia and Hemiparesis or Acquired Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective: To determine changes in physiological and structural properties of upper limb muscles with spasticity in patients with acquired brain injury after applying neural mobilization improving their functional performance, their participation in society and quality of life. Hypothesis: Peripheral nerve mobilizations performed with neurodynamic techniques in upper limb in patients with acquired brain injury, generate changes at structural and physiological level, favoring the performance of daily life activities and improving the quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preparatory use of neurodynamics to enhance upper limb function in patients with acquired brain injury: a randomized controlled trial.
    Salniccia F, Castel-Sánchez M, Bermejo-Franco A, Buesa-Estéllez A, et al · · 2025 · PMID 41318749 · DOI 10.1038/s41598-025-29095-y

Verify or expand the search:

Other trials of Neurodynamic

Trials testing the same drug.

Other recruiting trials for Hemiplegia and Hemiparesis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04652934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing